Aluna
Aluna builds an FDA-cleared portable digital spirometer and companion mobile app that enable daily at-home lung function monitoring for asthma and cystic fibrosis patients, serving also healthcare providers and clinical trial sponsors. Acquired by Huma Therapeutics in May 2025.
- Company typePrivate
- Founded2016
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Aluna does
Aluna is a digital health company that develops and sells a portable, FDA-cleared digital spirometer and companion mobile application for the daily monitoring of lung function by patients with asthma and cystic fibrosis. Founded in 2016 by Charvi Shetty (CEO) and Inderjit Jutla (CSO) out of UC Berkeley, the company combines a differential pressure sensor with a proprietary machine learning algorithm to deliver hospital-grade accuracy — validated against the nSpire Koko desktop reference system — in a Bluetooth-connected, USB-rechargeable consumer device with a removable mouthpiece. The ML pipeline performs 'adequate effort' quality detection, BTPS environmental corrections using phone-sensor inputs (barometer, accelerometer, internal temperature), and automated at-risk patient flagging. Aluna sells the device direct-to-consumer through alunacare.com (US-only), operates a web-based Provider Dashboard for remote patient monitoring with CPT-code billing workflows, and offers a Clinical Trials Platform for CROs and academic institutions. Revenue is generated through one-time hardware sales and recurring subscription/app services processed via Stripe and Apple App Store. The company was acquired by Huma Therapeutics in May 2025 and now operates as a subsidiary of Huma Therapeutics Inc.
Aluna firmographics
Firmographics- Name
- Aluna
- Legal name
- Huma Therapeutics Inc
- Website
- https://alunacare.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Aluna builds an FDA-cleared portable digital spirometer and companion mobile app that enable daily at-home lung function monitoring for asthma and cystic fibrosis patients, serving also healthcare providers and clinical trial sponsors. Acquired by Huma Therapeutics in May 2025.
- Ownership category
- akta.pro rank
Aluna industry classification
Industry- Product category
- Digital Respiratory Health Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Pulmonary Function Testing (PFT) & Spirometry Equipment (HLAHAGAH)
- akta.pro secondary industries
- Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate) (HLAHAGAI)
Keywords
Where Aluna is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Aluna business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Hardware Device Sales: Aluna sells its digital spirometer device directly to consumers and healthcare providers. The device is available for purchase through the website and connects to the companion app via Bluetooth.
- Subscription Services: Aluna offers subscription billing for app services. Credit card payment processing is handled through Stripe and Apple App Store. Subscription includes access to app features, data storage, and provider connectivity.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Hybrid | Monthly | Device + Subscription |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels4 records
Aluna product offering
Product offeringCore offering
Aluna sells an FDA-cleared portable digital spirometer that pairs via Bluetooth with a companion mobile app to measure and track lung function (FEV1%, PEF), symptoms, medications, and environmental factors for asthma and cystic fibrosis patients. The platform extends to a web-based Provider Dashboard for remote patient monitoring with CPT-code billing support, and a Clinical Trials Platform for CROs and academic researchers conducting respiratory studies.
Product overview
Aluna offers a connected health platform centered on an FDA-cleared portable digital spirometer that connects via Bluetooth to a companion mobile app. The platform includes a provider dashboard for remote patient monitoring and a dedicated clinical trials solution. Together, these products enable patients and healthcare providers to track lung function (FEV1%, PEF), symptoms, medications, and environmental factors; receive AI-powered quality analysis and risk alerts; and share data for telehealth, clinical care, and research purposes. Aluna is part of Huma Therapeutics and was acquired in May 2025.
Differentiator
Problem solved
Functional benefit
Products and services
- Aluna Digital Spirometer An FDA-cleared portable digital spirometer that measures lung function (FEV1%, PEF) via Bluetooth, featuring hospital-grade accuracy through differential pressure sensor technology, a removable mouthpiece, USB charging, and suitability for both OTC and prescription use by adults and children ages 5+.
- Aluna Companion App A mobile application that syncs with the Aluna device via Bluetooth to display real-time lung health scores, log symptoms and medications, track environmental factors, gamify daily testing with rewards and challenges, and enable users to share up to 3 months of data with healthcare providers.
- Aluna Provider Dashboard A web-based clinical portal enabling healthcare providers to remotely monitor patient lung health data, automatically flag at-risk patients, sort tasks by billing code, track time spent per patient, and access flow-volume curves, environmental factors, medication usage, respiratory symptoms, and exercise data for telehealth and reimbursement purposes.
- Aluna Clinical Trials Platform A clinical research solution providing portable digital spirometry with hospital-grade accuracy, real-time participant data monitoring, algorithmic quality control for spirometry effort, automated flagging of at-risk participants, and an intuitive portal for study management across pediatric and adult populations.
Quantifiable outcome
- Hospital-grade accuracy equivalent to nSpire Koko desktop system
- +1 more outcomes
Companies that use Aluna
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Aluna technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature5 records
Aluna partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Huma TherapeuticscoreHuma Therapeutics acquired Aluna in May 2025. Huma is a digital health company specializing in remote patient monitoring and digital health platforms. Aluna operates as part of the Huma Group following the acquisition, with Huma's privacy policy now governing Aluna's data practices. The acquisition reflects intensifying competition among digital health providers.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Aluna competitors and assessment
Company assessmentDirect peers
- Cohero Health: Cohero Health develops connected respiratory devices (spirometers and inhalers) and a SaaS platform for asthma and COPD management. It directly overlaps with Aluna's patient app + provider dashboard model.
- MIR (Medical International Research): MIR manufactures portable, connected spirometers (e.g., Spirobank, Smart One) used in clinical, occupational, and home settings, with Bluetooth pairing to mobile apps. It is a direct hardware-and-app competitor to Aluna's spirometer.
- nSpire Health: nSpire Health manufactures the Koko desktop spirometer used as the accuracy benchmark for Aluna. It sells clinical-grade pulmonary function testing systems to hospitals, CROs, and research institutions, competing with Aluna in the clinical-trials and provider segments.
- Propeller Health: Propeller Health (owned by ResMed) is a digital respiratory health company offering connected inhalers and an adherence platform for asthma and COPD. It competes for the same provider pharma-adherence budgets as Aluna and is the most-recognized brand in connected respiratory.
- NDD Medical Technologies (EasyOne): NDD Medical Technologies makes the EasyOne line of portable spirometers used in primary care, occupational health, and clinical trials. Its ultrasound-based flow sensor and broad clinical footprint make it a direct competitor in portable spirometry hardware.
- NuvoAir: NuvoAir is a direct competitor offering a digital respiratory health platform combining a connected home spirometer, app, and clinician dashboard for asthma and COPD management. Its DTC-to-enterprise model, multi-condition scope, and European footprint overlap directly with Aluna's core offering.
- Vitalograph: Vitalograph is a long-established manufacturer of clinical and home spirometers (e.g., In2itive, lung monitor) used by healthcare professionals, occupational health, and clinical trials. It competes in both consumer home and clinical trial channels.
Broad incumbents
- ResMed: ResMed is a global leader in sleep and respiratory care, owning Propeller Health. Its MyAir platform and connected CPAP/respiratory devices make it a broad incumbent competitor with overlapping digital-respiratory capabilities.
- Huma Therapeutics: Huma Therapeutics is Aluna's parent company following the May 2025 acquisition. It is a broader digital-health / remote-patient-monitoring platform with disease-agnostic modules; its overall platform strategy and RPM distribution directly influence Aluna's go-to-market.
Emerging players
- Adherium: Adherium provides digital respiratory health solutions, including smart inhaler sensors and a connected adherence platform for asthma and COPD. It is an emerging player with partial product overlap with Aluna's connected respiratory approach.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Aluna social profiles
Digital presenceAluna compliance and trust
Trust signalCompliance4 records
Aluna financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aluna leadership team
Management profileNumber of profiles
Profiles2 records
Aluna funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aluna M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aluna
What does Aluna do?
Aluna sells an FDA-cleared portable digital spirometer that pairs via Bluetooth with a companion mobile app to measure and track lung function (FEV1%, PEF), symptoms, medications, and environmental factors for asthma and cystic fibrosis patients. The platform extends to a web-based Provider Dashboard for remote patient monitoring with CPT-code billing support, and a Clinical Trials Platform for CROs and academic researchers conducting respiratory studies.
Is Aluna a public or private company?
Aluna is a private company. It is classified as corporate owned and is currently acquired.
When was Aluna founded?
Aluna was founded in 2016. It employs 11 to 50 people.
Where is Aluna based?
Aluna is headquartered in San Francisco, United States, in the North America region.
How does Aluna make money?
Two revenue lines are on record. Hardware Device Sales are the primary driver. The others are subscription Services.
Who are Aluna's main competitors?
Direct peers on record are Cohero Health, MIR (Medical International Research), nSpire Health, Propeller Health, NDD Medical Technologies (EasyOne), NuvoAir and Vitalograph. Broad incumbents are ResMed and Huma Therapeutics. Adherium is listed as an emerging player.
Does Aluna have an API?
No public API is recorded for Aluna.
What industry is Aluna in?
Aluna's product category is Digital Respiratory Health Devices. Its primary akta.pro industry code is HLAHAGAH, Pulmonary Function Testing (PFT) & Spirometry Equipment, with a secondary code of HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers). Its NAICS code is 334510 and its SIC code is 3841.